ABVC BIOPHARMA, INC. (ABVC) Files Proxy Statement Ahead of Shareholder Meeting
ABVC BIOPHARMA, INC. (NASDAQ:ABVC) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on March 05, 2026. The Healthcare company's proxy…
Read more
